Skip to main content
Home Startups Adaptin Bio

Adaptin Bio

Adaptin Bio, is a pioneering biotechnology company dedicated to revolutionizing drug delivery. Our focus is on developing innovative technologies that enhance how medications and other therapeutic compounds reach their target destinations within the body.
Our core mission is to overcome a major hurdle in medicine: ensuring effective delivery of drugs to specific tissues.
Many critical medications and diagnostic tools struggle to reach the areas where they can have the most significant impact. The blood-brain barrier that protects the central nervous system being the most famous example.
Adaptin Bio’s precision medicine technologies are designed to address this challenge. We are creating methods to deliver drugs and other compounds directly to their target sites, maximizing their effectiveness and minimizing potential side effects.

Lead Product


APTN-101: This is a proprietary BRiTE therapeutic designed to target EGFRvIII, a specific protein associated with aggressive brain tumors. Preclinical studies show significant promise for APTN-101 in eliminating these tumors. We are actively working towards our first human trial.
NOTE: Adaptin Bio was formerly named Centaur Bio.